LegisTrack
Back to all bills
HR 2005119th CongressIn Committee

DMEPOS Relief Act of 2025

Introduced: Mar 10, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs

The DMEPOS Relief Act of 2025 would direct the Secretary of Health and Human Services to adjust Medicare payments for durable medical equipment (DME) that were previously set under the 2021 round of the DMEPOS competitive bidding program. The bill primarily creates a transitional pathway to ease or postpone certain price adjustments in Medicare payments. Specifically, it requires applying the transition rule for non-rural, noncontiguous areas through December 31, 2025, and postpones another related transition for all areas until January 1, 2026. The Secretary would have flexibility to implement these changes by program instruction. In short, the bill aims to provide temporary relief for how DME payments are updated under the DMEPOS bidding framework, delaying deeper or nationwide changes through the end of 2025 (and into 2026 for the broader stage).

Key Points

  • 1The bill is titled the “DMEPOS Relief Act of 2025” and concerns Medicare payment adjustments for items formerly included in Round 2021 of the DMEPOS competitive bidding program.
  • 2For areas that are not rural or noncontiguous, the Secretary must apply the transition rule described in 42 CFR 414.210(g)(9)(v) to all applicable DMEPOS items through December 31, 2025.
  • 3The implementation of the subsequent nationwide transition rule described in 42 CFR 414.210(g)(9)(vi) is postponed; it cannot take effect until January 1, 2026.
  • 4The Secretary can implement these provisions by program instruction or other methods, providing administrative flexibility.
  • 5The bill would be in effect for the 119th Congress and was introduced in March 2025 by Rep. Miller-Meeks (with several co-sponsors) and referred to the relevant committees (Energy and Commerce; Ways and Means).

Impact Areas

Primary group/area affected: DMEPOS suppliers and Medicare beneficiaries in non-rural, noncontiguous areas, who would see a longer transitional period before deeper payment adjustments take effect.Secondary group/area affected: DMEPOS manufacturers and suppliers nationwide, who rely on Medicare payment levels; potential changes in pricing, revenue planning, and market stability during the extension.Additional impacts: The bill provides administrative flexibility (program instruction) to implement the changes, which could affect how quickly or slowly price adjustments are deployed; potential implications for Medicare spending and beneficiary out-of-pocket costs during the extended transition.
Generated by gpt-5-nano on Nov 19, 2025